TY - JOUR
T1 - Reproductive cycle of the pearl oyster Pteria sterna (Pteriidae) in the Ojo de Liebre lagoon, B.C.S., Mexico
AU - Hernández-Olalde, Liliana
AU - García-Domínguez, Federico
AU - Arellano-Martínez, Marcial
AU - Ceballos-Vázquez, Bertha Patricia
N1 - Funding Information:
Trial funding: the trial was supported by clinical research grant from Pusan National University Hospital
Funding Information:
Data of 2 intervention groups combined for dichotomous outcomes and cod liver oil vs control data used for continuous outcomes Trial funding: the trial was supported by the program Medical Research in Finnmark County, University of Tromsø
Funding Information:
Main trial outcome: change in cognitive performance Dropouts: not reported Available outcomes: mortality (nil), MI, stroke, revascularisation, atrial fibrillation, CV events. Planned outcomes, not reported in publications, included: cognitive outcomes, functional outcomes, glucose, lipids, plasma fatty acids, BP, inflammation and oxidative stress Response to contact: yes (data provided) Trial authors reported some events, but don’t appear to be published Trial funding: EPAX donated the Omega-3 concentrate and Blackmores Pty Ltd donated the placebo and packaging of the Omega-3 concentrate. The trial was supported by the Brailsford Robertson Award 2007-2008 (University of Adelaide and CSIRO Food and Nutritional Sciences), and is funded by a National Health and Medical Research Project Grant (#578800)
Funding Information:
by a grant from the NHLBI, NIH
Funding Information:
Trial funding: the trial was funded in part by the National Heart Foundation of Australia and the Pfizer Cardiovascular Lipid Research Grant
Funding Information:
Trial funding: National Heart Foundation of New Zealand, Aukland Medical Research Foundation, Lotteries Medical Board and the Health Research Council of New Zealand NOTE: total PUFA intake lower in intervention than control group
Funding Information:
Trial funding: funded by the National Science Foundation of Sri Lanka
Funding Information:
Main trial outcome: probability of maintenance of sinus rhythm Dropouts: 6 intervention, 5 control Available outcomes: adverse events, AF recurrence (nil death) Response to contact: no (contact established with trial author but no data received in this trial) Trial funding: ‘Centro per lo Studio ed il Trattamento dello Scompenso Cardiaco’ of the University of Brescia, Brescia, Italy. The work of Dr Campia was supported by National Institutes of Health grant K12 HL083790-01a1
Funding Information:
Main trial outcome: safety outcomes and adverse events Dropouts: 8 G1, 14 G2, 21 G3 Available outcomes: adverse events (including CVD events, cancers), CRP, waist circumference, weight, BP (nil death), lipids provided as % change from baseline, but no baseline data available, so not used in meta-analyses Response to contact: contact attempted but no response to date A third arm of EPA-E 1.8 g supplementation is not used here. Outcome data used TAK-4 vs TAK-2 Trial funding: funded by Takeda Pharmaceutical Company
Funding Information:
Trial funding: supported by The Danish Heart Association. Eskisol Fish oil and placebo oil emulsions were provided by Pharma-Vinci A/S, Frederiksvaerk, Denmark
Funding Information:
Trial funding: Life Insurance Medical Research Fund of Australia and New Zealand
Funding Information:
Main trial outcome: changes in mean liver fat %, changes in 2 liver fibrosis scores, change in serum biomarkers Dropouts: 4 intervention, 4 control Available outcomes: weight, BMI, lipids, BP, glucose, insulin sensitivity, body fat measures, liver enzymes, HbA1c, serum n-3 fatty acids, trial authors provided details of diabetes diagnoses, % body fat, BP and carotid intima media thickness Response to contact: yes Trial funding: Omacor and placebo were provided by Pronova Biopharma through Abbott Laboratories, Southampton, UK. This work was supported by a National Institute for Health Research (NIHR) Southampton Biomedical Research Unit grant and by a Diabetes UK Allied Health Research training fellowship awarded to KGM (Diabetes UK. BDA 09/ 0003937). CDB, PCC and ES were supported in part by the NIHR Southampton Biomedical Research Centre (McCormick-2015, p9; see WELCOME 2015)
Funding Information:
ASA: This review was funded by a grant from the World Health Organization.
Funding Information:
XW: This review was funded by a grant from the World Health Organization.
Funding Information:
JSB: This review was funded by a grant from the World Health Organization.
Funding Information:
TJB: This review was funded by a grant from the World Health Organization.
Funding Information:
SH: This review was funded by a grant from the World Health Organization.
Funding Information:
OFJ: This review was funded by a grant from the World Health Organization.
Funding Information:
SMAA: This review was funded by a grant from the World Health Organization.
Funding Information:
FS: This review was funded by a grant from the World Health Organization.
Funding Information:
KHOD: This review was funded by a grant from the World Health Organization.
Funding Information:
LH: This review was funded by a grant from the World Health Organization.
Funding Information:
• University of East Anglia, UK. • Cochrane Heart Group, UK. This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Heart Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health, UK
PY - 2007/8
Y1 - 2007/8
N2 - The reproductive cycle of a wild population of the oyster pearl Pteria sterna living in the Ojo de Liebre lagoon was analyzed from February 2001 to February 2002. The gonadic development was studied both qualitatively (through histological analysis) and quantitatively (through an analysis of the percent follicular area). P. sterna's gonadic development consists of five stages (undifferentiated, developing, ripe, spawning, and spent). The percent follicular area turned out to be an adequate quantitative indicator of reproductive activity, with significantly higher values in the ripe months (August to September) and with a decrease directly related to spawning. The reproductive cycle of P. sterna is synchronic and is influenced by temperature and food availability. The reproductive season can be regarded to range from October to April, starting when temperature drops. The size at first maturity was determined at 117.1 mm SH and 106.6 mm SH for females and males, respectively. However, the smallest ripe female and male measured 73 mm SH and 26 mm SH. respectively, and both were undergoing the spawning phase. Differences in the reproductive cycle of P. sterna were found between the one reported here and reports for other Gulf of California's localities.
AB - The reproductive cycle of a wild population of the oyster pearl Pteria sterna living in the Ojo de Liebre lagoon was analyzed from February 2001 to February 2002. The gonadic development was studied both qualitatively (through histological analysis) and quantitatively (through an analysis of the percent follicular area). P. sterna's gonadic development consists of five stages (undifferentiated, developing, ripe, spawning, and spent). The percent follicular area turned out to be an adequate quantitative indicator of reproductive activity, with significantly higher values in the ripe months (August to September) and with a decrease directly related to spawning. The reproductive cycle of P. sterna is synchronic and is influenced by temperature and food availability. The reproductive season can be regarded to range from October to April, starting when temperature drops. The size at first maturity was determined at 117.1 mm SH and 106.6 mm SH for females and males, respectively. However, the smallest ripe female and male measured 73 mm SH and 26 mm SH. respectively, and both were undergoing the spawning phase. Differences in the reproductive cycle of P. sterna were found between the one reported here and reports for other Gulf of California's localities.
KW - First maturity
KW - Follicular area
KW - Gonadic cycle
KW - Histology
KW - Oyster
KW - Pteria
UR - http://www.scopus.com/inward/record.url?scp=36649031441&partnerID=8YFLogxK
U2 - 10.2983/0730-8000(2007)26[543:RCOTPO]2.0.CO;2
DO - 10.2983/0730-8000(2007)26[543:RCOTPO]2.0.CO;2
M3 - Artículo
SN - 0730-8000
VL - 26
SP - 543
EP - 548
JO - Journal of Shellfish Research
JF - Journal of Shellfish Research
IS - 2
ER -